JP2016534022A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016534022A5 JP2016534022A5 JP2016503264A JP2016503264A JP2016534022A5 JP 2016534022 A5 JP2016534022 A5 JP 2016534022A5 JP 2016503264 A JP2016503264 A JP 2016503264A JP 2016503264 A JP2016503264 A JP 2016503264A JP 2016534022 A5 JP2016534022 A5 JP 2016534022A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- variable region
- set forth
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013158258 | 2013-07-30 | ||
| JP2013158258 | 2013-07-30 | ||
| PCT/JP2014/070661 WO2015016386A1 (en) | 2013-07-30 | 2014-07-30 | Medicament comprising anti-phospholipase d4 antibody |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018206702A Division JP2019014759A (ja) | 2013-07-30 | 2018-11-01 | 抗ホスホリパーゼｄ４抗体を含む医薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016534022A JP2016534022A (ja) | 2016-11-04 |
| JP2016534022A5 true JP2016534022A5 (enExample) | 2017-09-07 |
| JP6431523B2 JP6431523B2 (ja) | 2018-11-28 |
Family
ID=51493000
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503264A Active JP6431523B2 (ja) | 2013-07-30 | 2014-07-30 | 抗ホスホリパーゼｄ４抗体を含む医薬 |
| JP2018206702A Ceased JP2019014759A (ja) | 2013-07-30 | 2018-11-01 | 抗ホスホリパーゼｄ４抗体を含む医薬 |
| JP2019173621A Active JP6843449B2 (ja) | 2013-07-30 | 2019-09-25 | 抗ホスホリパーゼｄ４抗体を含む医薬 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018206702A Ceased JP2019014759A (ja) | 2013-07-30 | 2018-11-01 | 抗ホスホリパーゼｄ４抗体を含む医薬 |
| JP2019173621A Active JP6843449B2 (ja) | 2013-07-30 | 2019-09-25 | 抗ホスホリパーゼｄ４抗体を含む医薬 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20160168266A1 (enExample) |
| EP (1) | EP3027656B1 (enExample) |
| JP (3) | JP6431523B2 (enExample) |
| KR (1) | KR102367760B1 (enExample) |
| CN (1) | CN105745226B (enExample) |
| AU (1) | AU2014297217B2 (enExample) |
| BR (1) | BR112016002001B1 (enExample) |
| CA (1) | CA2919736C (enExample) |
| DK (1) | DK3027656T3 (enExample) |
| ES (1) | ES2736324T3 (enExample) |
| HU (1) | HUE044469T2 (enExample) |
| MX (1) | MX381725B (enExample) |
| PL (1) | PL3027656T3 (enExample) |
| RU (1) | RU2709741C2 (enExample) |
| SG (2) | SG10201800592SA (enExample) |
| TR (1) | TR201910330T4 (enExample) |
| WO (1) | WO2015016386A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20210044A1 (ar) | 2010-12-30 | 2017-06-16 | Takeda Pharmaceuticals Co | الأجسام المضادة لـ cd38 |
| CN104284903B (zh) * | 2012-01-31 | 2020-10-09 | Sbi生物技术有限公司 | 抗磷脂酶d4抗体 |
| PL3027656T3 (pl) * | 2013-07-30 | 2019-10-31 | Sbi Biotech Co Ltd | Lek zawierający przeciwciało anty-fosfolipazowe D4 |
| EP3484923A1 (en) | 2016-07-15 | 2019-05-22 | Takeda Pharmaceutical Company Limited | Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies |
| US12371506B2 (en) | 2018-01-12 | 2025-07-29 | Takeda Pharmaceutical Company Limited | Subcutaneous administration of anti-CD38 antibodies |
| JP7140367B2 (ja) * | 2018-05-31 | 2022-09-21 | 国立大学法人 東京大学 | ヒト由来サンプルにおける可溶型ｔｌｒ７の分析 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69303494T2 (de) * | 1992-11-13 | 1997-01-16 | Idec Pharma Corp | Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma |
| WO2000011015A1 (en) * | 1998-08-24 | 2000-03-02 | Alphagene, Inc. | Secreted proteins and polynucleotides encoding them |
| US20020146686A1 (en) * | 2000-12-07 | 2002-10-10 | Millennium Pharmaceuticals, Inc. | Methods and compositions for the diagnosis and treatment of viral disease using 55092 |
| JP2013052781A (ja) | 2011-09-05 | 2013-03-21 | Tokai Rika Co Ltd | 車両用ミラー装置 |
| CN104284903B (zh) * | 2012-01-31 | 2020-10-09 | Sbi生物技术有限公司 | 抗磷脂酶d4抗体 |
| PL3027656T3 (pl) * | 2013-07-30 | 2019-10-31 | Sbi Biotech Co Ltd | Lek zawierający przeciwciało anty-fosfolipazowe D4 |
-
2014
- 2014-07-30 PL PL14761423T patent/PL3027656T3/pl unknown
- 2014-07-30 SG SG10201800592SA patent/SG10201800592SA/en unknown
- 2014-07-30 BR BR112016002001-4A patent/BR112016002001B1/pt active IP Right Grant
- 2014-07-30 TR TR2019/10330T patent/TR201910330T4/tr unknown
- 2014-07-30 EP EP14761423.4A patent/EP3027656B1/en active Active
- 2014-07-30 SG SG11201600666SA patent/SG11201600666SA/en unknown
- 2014-07-30 AU AU2014297217A patent/AU2014297217B2/en active Active
- 2014-07-30 CA CA2919736A patent/CA2919736C/en active Active
- 2014-07-30 US US14/908,004 patent/US20160168266A1/en not_active Abandoned
- 2014-07-30 ES ES14761423T patent/ES2736324T3/es active Active
- 2014-07-30 MX MX2016001193A patent/MX381725B/es unknown
- 2014-07-30 WO PCT/JP2014/070661 patent/WO2015016386A1/en not_active Ceased
- 2014-07-30 KR KR1020167002746A patent/KR102367760B1/ko active Active
- 2014-07-30 RU RU2016106708A patent/RU2709741C2/ru active
- 2014-07-30 CN CN201480047721.6A patent/CN105745226B/zh active Active
- 2014-07-30 HU HUE14761423 patent/HUE044469T2/hu unknown
- 2014-07-30 DK DK14761423.4T patent/DK3027656T3/da active
- 2014-07-30 JP JP2016503264A patent/JP6431523B2/ja active Active
-
2018
- 2018-11-01 JP JP2018206702A patent/JP2019014759A/ja not_active Ceased
-
2019
- 2019-09-25 JP JP2019173621A patent/JP6843449B2/ja active Active
-
2020
- 2020-12-18 US US17/127,202 patent/US20210130493A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013060443A5 (enExample) | ||
| JP2016029056A5 (enExample) | ||
| JP2012012402A5 (enExample) | ||
| JP2013198490A5 (enExample) | ||
| JP2014111644A5 (enExample) | ||
| JP2015535828A5 (enExample) | ||
| JP2014205674A5 (enExample) | ||
| JP2013538057A5 (enExample) | ||
| JP2017505125A5 (enExample) | ||
| JP2013506675A5 (enExample) | ||
| RU2008129111A (ru) | Антитела к ox40l и способы их применения | |
| JP2012143232A5 (enExample) | ||
| JP2021500916A5 (enExample) | ||
| JP2017513813A5 (enExample) | ||
| JP2014511179A5 (enExample) | ||
| RU2015136078A (ru) | Антитело против с5 и способ предупреждения и лечения обусловленных комплементом заболеваний | |
| RU2013140350A (ru) | Антитела против человеческого il33r и их применение | |
| JP2018521691A5 (enExample) | ||
| EP4240758A1 (en) | Neutralizing anti-sars-cov-2 antibodies | |
| JP2012501669A5 (enExample) | ||
| JP2019534892A5 (enExample) | ||
| JP2016516400A5 (enExample) | ||
| JP2014518883A5 (enExample) | ||
| JP2010526028A5 (enExample) | ||
| JP2015514094A5 (enExample) |